Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 15/20 | 0.47 |
| ▸ | PTGER3 | P43115 | 10/20 | 0.47 |
| ▸ | PTGER2 | P43116 | 8/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19513853 | 0.94 | PTGER4 (0.54) | PTGER4PTGER3PTGER2 | |
| SCHEMBL12301008 | 0.85 | PTGER4 (0.56) | PTGER4PTGER3PTGER2 | |
| SCHEMBL4681916 | 0.81 | CHRM2 (0.45) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL783054 | 0.79 | CHRM2 (0.46) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL1869119 | 0.79 | MEN1 (0.48) | PTGER4PTGER3PTGER2CHRM2CHRM4 | |
| SCHEMBL7643090 | 0.77 | CHRM2 (0.45) | PTGER4PTGER3PTGER2CHRM2CHRM4 | |
| SCHEMBL4635213 | 0.77 | CHRM2 (0.45) | PTGER4PTGER3PTGER2CHRM2CHRM4 | |
| SCHEMBL1857037 | 0.77 | CHRM2 (0.45) | PTGER4PTGER3PTGER2CHRM2CHRM4 | |
| SCHEMBL19513774 | 0.77 | KAT2B (0.42) | PTGER4PTGER3PTGER2CHRM2CHRM4 | |
| SCHEMBL4338414 | 0.77 | CHRM2 (0.47) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858650-B2 | Medicinal composition for inhalation | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20080114043-A1 | Medicinal Composition for Inhalation | ONO PHARMACEUTICAL CO., LTD (JP) | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080114043-A1 | Medicinal Composition for Inhalation | PTGER2, PTGER1, PTGIS | PTGER4 10/4885PTGER3 6/4885PTGER2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.